Share this post on:

Product Name :
99mTc-3PRGD2

Search keywords :
RGD

drugId :
null

Target Vo:
Integrin alpha-V/beta-3

Target Vo Short Name :
ITGAV&ITGB3

Moa_Name:
Integrin alpha-V/beta-3 modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Peking University

Active Company_Name :
Foshan Rui Diao Pharmaceutical Co Ltd

Active Indication_Name:
Lung Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PI3 Kinase p55 gamma Antibody
Cy3-conjugated AffiniPure Goat Anti-Mouse IgG H&L
8-OHdG (DNA/RNA Damage) Antibody: 8-OHdG (DNA/RNA Damage) Antibody is an unconjugated, approximately 0.283 kDa, rabbit-derived, anti-8-OHdG (DNA/RNA Damage) polyclonal antibody. 8-OHdG (DNA/RNA Damage) Antibody can be used for: ELISA, IHC-P, IHC-F, IF expriments in human, background without labeling.

Share this post on:

Author: Interleukin Related